Definitive Contract 75F40123C00051
- Not listed
- This is a firm-fixed-price definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The contract is for expert witness services related to the proposal to withdraw approval of an Abbreviated New Drug Application (ANDA). The contract has a potential value of $439,466.00 and a completion date of December 31, 2022. Caitta Inc. has a history of...
- This is a sole source 8(a) contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Caitta Inc., an SBA certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for expert witness services in support of the FDA's proposal to withdraw approval of abbreviated new drug applications (ANDAs) for extended-release methylphenidate tablets. The potential contract value is $137,100.00 with a completion date of September...
- Caitta Inc. was awarded a $514,325 definitive contract by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to retain expert witness services for both compounding and non-compounding related injunctions. The contract has an 8(a) sole source set aside designation for Caitta as an SBA-certified economically disadvantaged woman-owned small business. Work will be performed in Herndon, Virginia through September 2023 and utilizes a labor hours pricing structure. This...
- This is a $2,485,367.54 definitive contract awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, by the Food and Drug Administration (FDA). The contract is for expert services related to SharePoint, expert witnesses, and data integrity. It is an 8(a) sole source contract with a period of performance through April 4, 2025. Caitta Inc. specializes in providing scientific, technical, and administrative services to...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The $524,377.60 contract is for the services of a senior subject matter expert, with a completion date of June 21, 2020. Caitta is an experienced contractor providing scientific, technical, and administrative services to federal agencies in the public health domain....
- The Department of Health and Human Services Food and Drug Administration awarded a $217,346.52 firm fixed price purchase order to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The award is for contractor support services, with a performance period ending on May 3, 2023. Caitta has a history of providing scientific, technical, and administrative services to HHS and its agencies, including the FDA, NIH, and NIST, through both competitive awards and...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The contract, valued at $450,792.12, is for subject matter expert support services to be performed in Silver Spring, Maryland. Caitta provides scientific, technical, and administrative services to federal agencies, with a focus on public health and regulatory functions. The...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for temporary administrative staffing services to support the FDA's Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ). The contract has a firm fixed price ceiling value of $23,870.00 and a period of performance through October 13, 2024. Caitta Inc. is the prime contractor and there are no...
- This is a $266,000.00 Firm Fixed Price Purchase Order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) program participant. The contract is for a "Precedent Based Approach to Support Decision-Making Oncology", and was awarded as an 8(a) Sole Source contract. Caitta Inc. is a federal contractor that specializes in providing scientific, technical, and...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price delivery order contract to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business (EDWOSB), for "PATIENT LEVEL ANALYSIS OF BENEFIT AND RISK" services. The $270,617.52 contract, which does not have a set-aside designation, was awarded on September 21, 2018 with a completion date of September 20, 2019. Caitta provides scientific, technical, and...
The Food and Drug Administration (FDA) awarded a $360,225 time and materials contract to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business, for outside expert witness services related to a proposal to withdraw approval of Abbreviated New Drug Applications (ANDAs). This contract, awarded on April 28, 2023, with a completion date of April 30, 2028, was designated as an 8(a) sole source set-aside and will be performed in Silver Spring, Maryland. The engagement involves providing specialized expert witness support for FDA regulatory proceedings concerning ANDA withdrawal decisions, leveraging external expertise to strengthen the agency's position in formal drug approval matters. Caitta Inc., headquartered in Herndon, Virginia, is well-positioned to support this regulatory mission through its established track record of providing scientific and professional services to federal agencies. The company's federal contract portfolio demonstrates extensive experience serving the FDA and other health-related agencies, including the National Institutes of Health, CDC, and USDA, across analytical instrumentation procurement and specialized technical services. This ANDA-related contract aligns with Caitta's strategic focus on regulatory consulting and public health support services, building upon its existing $2 million General Services Administration Federal Supply Schedule contract that encompasses multiple labor categories including epidemiology support, research science, and specialized consulting services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Supplemental Agreement for work within scope | $0 | 4/19/26 | |
| P00003 | Change Order | $0 | 11/21/25 | |
| P00002 | Other Administrative Action | $0 | 4/9/25 | |
| P00001 | Other Administrative Action | $0 | 3/18/24 | |
| Not listed | Not listed | $240.0k | 4/28/23 |